Adagene (NASDAQ:ADAG) reported quarterly losses of $(0.24) per share which missed the analyst consensus estimate of $(0.15) by 60 percent. This is a 52.94 percent increase over losses of $(0.51) per share from the same period last year. The company reported quarterly sales of $7.671 million which beat the analyst consensus estimate of $1.667 million by 360.26 percent. This is a 7.33K percent increase over sales of $103.204 thousand the same period last year.